¿De qué se trata el estudio? Opill, la primera pastilla anticonceptiva diaria disponible sin receta en los EE. UU., se puso a la venta...
Projects
From 2015-2021, Ibis collaborated with P.I. Dr. Silvia DeZordo at the University of Barcelona and Co-I Dr. Joanna Mishtal at the University of...
What is the study about? Opill–the first daily birth control pill available without a prescription in the US–became available online and...
Birth control pills are an essential part of the full range of sexual and reproductive health care and are one of the best-studied medicines on the...
Beyond the legal and access barriers that women experience, stigma and social barriers impact and delay women’s ability to access safe, high-...
Improving the quality of care provided in the reproductive health setting can lead to the provision of better care, increased access to and use of...
All people have the right to access safe, high-quality, affordable, stigma-free abortion throughout pregnancy. Several state and federal policies and...
Several legislative policies restrict insurance coverage of abortion, forcing people—many of whom are working to make ends meet—to pay...
Almost no research to date has examined the abortion needs of Asian Americans, Native Hawaiians, and Pacific Islanders (AANHPIs) in the United States...
mmoho is a nationwide advocacy campaign developed by Ibis Reproductive Health and partners working to advance sexual and reproductive health (SRH) of...